Policy Number: SRP 007
Policy Name: Medical Technologies Funding Mandate
Status: Overarching commissioning policy
Effective Date: 1 April 2024
Next Review Date: 1 April 2026
The NHS Long Term Plan committed to accelerate the uptake of selected innovative medical devices, diagnostics, and digital products, by developing the MedTech Funding Mandate (MTFM) policy that launched on 1 April 2021. The MTFM aims to ensure patients and the NHS benefit from clinically effective and cost saving medical technologies faster and more equitably.
The MTFM policy builds on prior NHS Accelerated Access Collaborative (AAC) innovation programmes, such as the Innovation and Technology Tariff/Payment Programme (ITT/ITP), introduced to address financial and procurement barriers to the adoption of devices, diagnostics and digital products.
Technologies covered by the MTFM are typically funded by commissioners from their existing allocations. This is deliverable as the technologies supported are National Institute for Health and Care Excellence (NICE) recommended and meet the criteria to save costs and resources and make a return on investment within three years.
For the 2024/25 financial year, an updated version of the guidance document has been published. Read the updated guidance here.
Further information can be found here
Accordingly, implementation of technologies covered by the MedTech Funding Mandate, where they are ICB commissioned, will be subject to the annual commissioning prioritisation process and funded from within existing resources.